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Phosphorus intake regulates intestinal function and polyamine metab-
olism in uremia. This study found that 5/6-nephrectomized uremic rats
showed secondaiy hyperparathyroidism as reflected by an increase in their
serum parathyroid hormone (PTH) level in association with a decrease in
serum 1,25-dihydroxyvitamin D [1,25-(OH)2D]. These changes recovered
partially upon phosphorus restriction. Calcium absorption and gene expres-
sion of calbindin-D9k were decreased in uremia and were also improved by
phosphorus restriction. In uremia, intestinal spermidine/spermine N1-acetyl-
transferase activity was decreased, while ornithine decarboxylase (ODC)
activity and its gene expression were potentiated. Enhancement of c-fos and
c-jun gene expressions was also observed in uremia. These phenomena
suggest that the intestinal villus may proliferate in uremia. Phosphorus
restriction prevented increases in the expression of ODC, c-fos and c-jun
observed in uremia. Since phosphorus restriction caused a rise in the serum
1,25-(OH)2D level, the role of 1,25-(OH)2D in uremia-induced intestinal
dysfunction was examined. A single injection of 1,25-(OH)2D3 to uremic rats
caused an increase in the steady-state calbindin-DSk mRNA level, and
decreases in steady state c-fos and ODC mRNA levels, suggesting that the
deficiency of 1,25-(OH)2D3 is responsible for intestinal dysfunction in uremia.
In conclusion, altered polyamine metabolism caused by 1,25-(OH)2D defi-
ciency is intimately involved in intestinal dysfunction and the development of
the proliferative state of the intestinal villus in uremia.
Renal insufficiency is characterized by several alterations in
mineral homeostasis. Uremic intoxication per se may lead to
reduced intestinal calcium absorption in the proximal segments of
the small intestine of patients [1—3] and rats [4]. Reduced renal
function results in phosphate retention [51, and the high level of
PTH with its severe effects on several organ systems are believed
to be an inevitable homeostatic response, which increases the
fractional excretion of phosphate [61. Renal dysfunction also leads
to low serum 1,25-dihydroxyvitamin D [1,25-(OH)2D], probably
due to phosphorus restriction and to the decreased activity of
lcs-hydroxylase in the kidney [7], which is essential for the
production of 1,25-(OH)2D. Low levels of 1,25-(OH)2D lead to
decreased serum calcium [3, 8] and enhanced synthesis and
secretion of parathyroid hormone (PTH) [9—14]. Secondary hy-
perparathyroidism occurs even in the early stage of renal insuffi-
ciency, and is followed by the development of renal osteodystro-
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phy [15]. Even at an early stage, chronic renal failure increases
PTH mRNA levels without altering serum 1,25-(OH)2D and
calcium levels [16]. The development of 1,25-(OH)2D resistance
in chronic renal failure is thought to reduce the action of
1,25-(OH)2D [17, 18].
In support of the major role of phosphorus retention [15, 19] in
the pathogenesis of secondary hyperparathyroidism, previous
reports have shown that the decreased phosphorus filtration rate
prevents [20] or ameliorates [21—23] secondary hyperparathyroid-
ism. Hyperphosphatemia results in hypocalcemia by several pos-
sible mechanisms, including inhibition of the activity of the renal
enzyme Ics-hydroxylase [7, 24], which is already limited by the
decrease in renal mass. In normal humans [25] and in patients
with moderate chronic renal failure [22, 231, restriction of dietary
phosphorus increases the production of 1,25-(OH)2D, thus de-
creasing the levels of immunoreactive PTH. However, phosphorus
restriction may reverse hyperparathyroidism in uremia by itself,
independently of any change in calcium or 1,25-(OH)2D [26].
Intracellular concentrations of polyamines are highly regulated
and they play essential roles in regulating cell growth and differ-
entiation. Ornithine decarboxylase (ODC) catalyzes the forma-
tion of putrescine from ornithine, a rate-limiting step in poly-
amine biosynthesis. Another rate-limiting enzyme, spermidine!
spermine N'-acetyltransferase (SAT), also participates in the
formation of putrescine from spermidine or spermine [27]. The
importance of polyamines in modulating cell growth and differ-
entiation is well established [28—301. Administration of vitamin D
to vitamin D-deficient chicks [31] or rats [32] resulted in a
considerable increase in the duodenal villus length. The duodenal
ODC and SAT activities increased markedly with a concomitant
increase in the duodenal content of putrescine after a single
injection of 1,25-(OH)2D3 into vitamin D-deficient chicks [33—35].
Putrescine is therefore intimately involved in vitamin D action in
modulating the morphological and functional development of the
intestinal villus [36]. However, the intestinal polyamine metabo-
lism in chronic renal failure is not well understood.
In the present investigation, intestinal functions related to
calcium absorption and polyamine metabolism were examined in
rats with chronic renal failure. The effects of a phosphorus
restricted diet and a single injection of 1,25-(OH)2D3 in uremic
rats were also examined to clarify the interaction between poly-
amine metabolism and 1,25-(OH)2D3 in the intestine of rats with
chronic renal failure.
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Methods
Materials
[a32P]-dCTP (3000 Ci/mmol) was purchased from Dupont/New
England Nuclear (Boston, MA, USA). Complementary DNA
(cDNA) for c-fos [37], c-jun [38], mouse ODC [39], calbindin-D9k
[40] and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
[41] were labeled with [ct32P]-dCTP using hexadeoxynucleotide
random primers. L-[1-14C] ornithine (2.96 mCi/mmol) and [1-4C]
acetyl coenzyme A (55 mCi/mmol) were purchased from Ameri-
can Radiolabeled Chemicals, Inc. (St. Louis, MO, USA) and ICN
Biochemicals Inc. (Costa Mesa, CA, USA), respectively.
Animals and study protocol
The protocol of the experiment was approved by the Animal
Research Committee of Osaka City University, and care of the
animals was in accordance with the standards of this institution
(Guide for Animal Experimentation, Osaka City University).
Uremic rats were produced by 5/6 nephrectomy as described
previously [18]. Both sham operated (Sham) and uremic rats were
maintained on a diet (Type B modified; Oriental Yeast Co., LTD.,
Tokyo, Japan) containing 1.09% calcium and 0.536% phosphate
for seven days after nephrectomy. Then the uremic rats were
divided into two groups; normal phosphorus diet (Uremic-N) and
phosphorus-restricted diet (Uremic-P). The diets contained
1.09% calcium and 2000 IU vitamin D3 per kg diet, and the
phosphorus concentrations of normal phosphorus diet and phos-
phorus-restricted diet were 0.536 and 0.136%, respectively. Sham
operated rats were maintained on a normal phosphorus diet
during the experiment. They were each fed a diet for seven weeks
before the study. The rats were fasted for 18 hours before the
experiments but were allowed to drink water freely. The rats were
bled by aortic puncture and sacrificed under ether anesthesia.
Serum was kept for biochemical analysis. The lumen and outer
surface of the excised duodenum were thoroughly rinsed with cold
phosphate buffered saline (PBS), and kept in cold PBS until used
for the determination of calcium transport. Some duodena were
frozen in liquid nitrogen, and stored at —80°C until used for
Northern blot and enzymatic analyses. To analyze the effect of a
single injection of 1,25-(OH)2D3, 2.0 tg/kg body wt of 1,25-
(OH)2D3 was administered intraperitoneally to some Uremic-N
rats. Duodena were collected and stored as described above until
used for Northern blot analysis.
Calcium absorption in rat intestine
In the intestines, intestinal 45Ca absorption was measured by
the everted gut-sac technique [42]. Data are expressed as the ratio
(S/M) of the tracer concentration in the serosal medium (inside
the sac) to the concentration of the tracer in the mucosal medium
(outside). In addition, the final tracer concentration in each
compartment is expressed as the percentage of the average tracer
concentration in the Sham group.
Measurement of enzyme activity
ODC activity was determined by the release of 14C02 formed
from L-[1-'4C] ornithine by the method described previously [43].
The frozen tissues were excised and homogenized with 4 vol of
ice-cold 10 mrvi Tris-HC1 (pH 7.5) containing 200 LM pyridoxal
phosphate, 0.1 mrvi EDTA, and 2.5 mM dithiothreitol. The homo-
genate was centrifuged at 30,000 X g for 30 minutes at 4°C. The
supernatant (90 tl) was added to glass tubes (12 X 100 mM)
containing 0.5 Ci of L-[1-14C1 ornithine (10 .il) and 80 nmol of
L-ornithine (10 jtl) each. The glass tubes were sealed with a
rubber stopper through which a syringe needle was placed. A
paper disk carrying 50 j.il of Soluene-350 (Packard Instrument
Company, Downers Grove, IL, USA) was impaled on the syringe
needle. The incubation time was 60 minutes at 37°C. The reaction
was terminated by adding 0.2 ml of 50% trichloroacetic acid and
the tube was incubated for an additional 60 minutes to trap 14C02
in Soluene-350 absorbed on the paper disk. The paper disk was
then transferred to a vial containing 5 ml of toluene-based
scintillation fluid (0.4% PPO, 0.01% POPOP) and counted for its
radioactivity by a Beckman liquid scintillation counter (LC 5801).
The extract for assay of SAT activity was prepared as described
previously [27]. The frozen tissues were excised and homogenized
with 4 vol of ice-cold 50 mrvi Tris-HC1 (pH 7.8) containing 0.25 M
sucrose. The homogenate was centrifuged at 105,000 X g for 60
minutes, and the resultant supernatant was used for the assay of
SAT activity. The supernatant was diluted with 4 vol of distilled
water, and 50 l aliquots of the supernatant were incubated with
0.3 imol of spermidine, 10 mol Tris-HCI (pH 7.8), and 40 nCi of
[1-14C]acetyl coenzyme A (C0A) in the final volume of 100 d at
37°C for 10 minutes. The reaction was terminated by chilling
followed by the addition of 20 jd of 1 M NH2OH-HC1; the reaction
mixture was placed in a boiling water bath for three minutes.
Aliquots of 50 jLl of the reaction mixture were spotted onto a
Whatman P81 paper disk (2.4 cm in diameter). The paper disk
was washed with tap water and then five times with 1 ml aliquots
of water followed by three washes with 1 ml aliquots of ethanol on
a filter. The paper disk was dried and transferred to a vial
containing 5 ml of toluene-based scintillation fluid, and the
incorporation of radioactivity into monoacetyispermidine was
measured with a Beckman liquid scintillation counter.
RNA isolation and hybridization
Total RNA was isolated from pooled duodena by acid
guanidinium thiocyanate-phenol-chloroform extraction [44].
Poly(A) -RNA was obtained by using oligo(dT)-latex (Takara
Shuzo Co., Ltd., Kyoto, Japan). The RNA was electrophoresed in
a 1% agarose gel containing formaldehyde, transferred to a nylon
filter (Hybond N, Amersham International, plc, Buckinghamshire,
UK). The nylon filter was prehybridized and hybridized as de-
scribed [18]. The density of each band was determined by a laser
densitometer and expressed as an arbitrary unit (AU).
Biochemical parameters
Serum calcium, phosphate, urea nitrogen and creatinine were
measured by an autoanalyzer. Serum PTH was measured by
radioimmunoassay using antibody raised against N-terminal rat
PTH [45]. The serum 1,25-(OH)2D level was determined as
described [46].
Statistical analysis
Value were expressed as the mean SD. Statistical analysis was
performed by Student's t-test or one-way ANOVA and multiple
comparison (Scheffe type).
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Table 1. Serum parameters of rats used in the experiment
Sham Uremic-N Uremic-P
N 16 20 21
Body weightg 472.1 37.3 309.8 91.4a 356.6 544
Urea nitrogen mg/dl 18.9 5.7 232.7 126.2a 183.9 117.5k'
Calcium mEqiliter 4.99 0.55 3.28 0.59a 5.71 0 63',
Phosphate mg/dl 5.68 0.76 15.91 793a 8.21 1.58
PTHpg/ml 73.1 40.4 1165.5 415.7a 215.2 171.2'
Values are expressed as the mean SD of 16 to 21 rats.
Abbreviations are: N, number of animals; PTH, parathyroid hormone;
Sham, sham operated rats; Uremic-N, 5/6 nephrectomized rats maintained
on a normal phosphorus diet; Uremic-P, 5/6 nephrectomized rats main-
tained on a phosphorus-restricted diet.
Variance analysis: a P < 0.05 vs. Sham; b P < 0.05 vs. Uremic-N
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Fig. 1. Serum 1,25-(OH)2D levels of rats used in the experiment. Uremic
and sham-operated rats (Sham) were produced as described in the
Methods section. Uremic rats were maintained on normal phosphorus diet
(Uremic-N) or phosphorus-restricted diet (Uremic-P) for seven weeks.
The serum 1,25-(OH)2D level was determined as described [46]. Values
are expressed as the mean SD of 16 to 21 rats. P < 0.05 vs. Sham;
< 0.05 vs. Uremic-N.
Results
Biochemical profiles of the uremic rats
The 5/6-nephrectomy resulted in characteristic changes in
chronic renal failure: characteristic body wt, serum urea nitrogen,
serum phosphate, serum calcium, serum PTH (Table 1) and
serum 1,25-(OH)2D levels (Fig. 1).
The uremic rats fed a normal phosphorus diet (Uremic-N) and
those fed a phosphorus restricted diet (Uremic-P) had reduced
body wts (P < 0.05) and significantly increased serum urea
nitrogen (P < 0.05) compared to the sham-operated rats (Sham).
Distinctive differences in calcium and phosphate metabolism
between the Sham group and the Uremic-N group were evident as
serum phosphate was significantly increased while serum calcium
was reduced in the Uremic-N group (P < 0.05). The Uremic-N
group also showed decreased serum 1,25-(OH)2D levels (P <
0.05) and increased serum PTH (P < 0.05), thus it appears to be
a relevant animal model for secondary hyperparathyroidism. The
phosphorus-restricted diet reversed the hypocalcemia, hyperphos-
phatemia, high concentration of serum PTH and low concentra-
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Fig. 2. Effects of uremia and phosphorus-restricted diet on rat intestinal
calcium absorption. Intestinal calcium absorption was studied as described
in the Methods section. Values are expressed as the mean SD of 16 to
21 rats. *p < 0.05 vs. Sham; P < 0.05 vs. Uremic-N.
tion of serum 1,25-(OH)2D levels observed in the Uremic-N
group (P < 0.05).
Calcium absorption and calbindin-D9k gene expression in the
intestine of uremic rats
Uremic-N group experienced a significant (84%) decrease in
intestinal calcium absorption compared to the Sham group, which
was restored to the level in the Sham group by phosphorus
restriction (Fig. 2). The changes in calcium absorption were partly
accompanied by the changes in calbindin-D9k gene expression
(Fig. 3). Steady-state levels of calbindin-DSk mRNA in the
intestine of Uremic-N group were significantly decreased (0.32
AU) compared to the Sham group (1.0 AU). The gene expression
was recovered partially in the Uremic-P group (0.62 AU) com-
pared to the Uremic-N group.
Polyamine metabolism and expression of proto-oncogenes in
uremic rats
Since polyamine metabolism is involved in cell proliferation and
function, we examined the metabolism of polyamine in the
intestine of uremic rats. The Uremic-N group experienced a
significant decrease (49.9%) in SAT activity compared to the
Sham group, which was reversed significantly to the level of Sham
group by phosphorus restriction in the Uremic-P group (89.6%)
(Fig. 4). Steady state levels of ODC mRNAs in the Uremic-N
group were significantly increased (1.7 AU) as compared to the
Sham group (1.0 AU), while the increment in such gene expres-
sion was partially normalized in the Uremic-P group (1.3 AU; Fig.
3). ODC activity was also significantly increased in the Uremic-N
group (463%), and the increase was partially normalized in the
Uremic-P group (200%) (Fig. 6). Steady state levels of c-fos and
c-jun mRNAs in the Urem ic-N group were increased (2.6 and 1.9
AU) as compared to the Sham group (1.0 AU), while the
increment in such gene expression was ameliorated in the Ure-
mic-P group (Fig. 5).
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Fig. 3. Effects of uremia and phosphorus-restricted diet on steady state
mRNA levels of calbindin-DSk and ODC. The steady-state mRNA level of
calbindin-D9k and ODC were examined by Northern blot analysis (10
jsgllane). A. Results of Northern blot analysis. B. The density of their
mRNA bands normalized to GAPDH mRNA levels. Sham mRNA levels
normalized to GAPDH mRNA level were expressed as 1.0 AU. The
calbindin-D9k mRNA is shown in the open bars and the ODC mRNA is
shown in the hatched bars. The blot shown is reproducible for two
independent experiments. *P < 0.05 vs. Sham.
Fig. 4. Effects of uremia and phosphorus-restricted diet on rat intestinal SAT
activity. SAT activity was studied as described in the Methods section.
Values are expressed as the mean SD of 12 rats. •p < 0.05 vs. Sham
**p < 0.05 vs. Uremic-N.
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Fig. 5. Effects of uremia and phosphorus-restricted diet on steady state
mRNA levels of c-fos and c-jun. The steady-state mRNA level of c-fos and
c-jun was examined by Northern blot analysis (20 jsgllane). Equal loading
of the gel was confirmed by ethidium bromide staining of the ribosomal
RNA. The blot shown is reproducible for two independent experiments.
1.2
'1 1.0
0.8
0.6O'i
o 0.4
0.2
0
Fig. 6. Effects of uremia and phosphorus-restricted diet on rat intestinal
ODC activity. ODC activity was studied as described in the Methods
section. Values are expressed as the mean so of five rats. < 0.05 vs.
Sham.
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Effect of a single injection of 1,25-(OH)2D3 on gene expressions in
uremic rats
To clarify whether 1,25-(OH)2D3 was involved in the beneficial
effect of phosphorus restriction in uremic rats, gene expressions of
calbindin-D9k, ODC, and c-fos after a single injection of 1,25-
(OH)2D3 (2 pg/kg body wt) were determined in uremic rats.
1,25-(OH)2D3 treatment caused an increase of steady state
calbindin-D9k mRNA at 2 to 24 hours (1.0, 1.186, 2.580, 2.687 and
2.993 AU for 0, 2, 6, 12 and 24 hr, respectively), while it caused
decreases in steady state levels of c-fos mRNA (1.0, 0.489, 0.389.
0.264 and 0.257 AU for 0, 2, 6, 12 and 24 hr, respectively) and of
ODC mRNA (1.0, 0.852, 0.516, 0.481 and 0.881 AU for 0, 2, 6, 12
and 24 hr, respectively; Fig. 7).
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Fig. 7. Effect of a single injection of 1,25-
(OH)2D3 on steady state mRNA levels of
calbindin-DQk, c-fos, and ODC. One microgram
of poly(A)RNA was used for Northern blot
analysis. A. Results of Northern blot analysis. B.
The density of their mRNA bands normalized
to GAPDH mRNA levels. Basal mRNA levels
normalized to GAPDH mRNA level at time 0
were expressed as 1.0 AU. The blot shown was
reproducible in two independent experiments.
Symbols are: (•) calbindin-D9k; (•) ODC; (E)
c-fos.
Discussion
This study shows that polyamine metabolism is altered in the
intestine of uremic rats. This alteration may be associated with
intestinal dysfunction. Moreover, polyamine metabolism seems to
be regulated by phosphate metabolism in chronic renal failure.
Our present data confirmed the previous finding that intestinal
calcium absorption was decreased in uremic rats [1, 2, 4]. This
impairment of function was completely restored by phosphorus
restriction, suggesting that phosphate metabolism plays an impor-
tant role in intestinal function in uremia. Our results could be
affected by differences in intake of other nutrients in addition to
phosphorus. We showed for the first time that polyamine metab-
olism was also altered in rat intestine with chronic renal failure.
ODC activity, which has been reported to have crucial roles in the
regulation of cell proliferation and differentiation, was increased
in the uremic intestine. This increase was also suppressed by a
phosphorus-restricted diet, indicating that intestinal ODC activity
as well as intestinal function was regulated by phosphate metab-
olism. Northern blot hybridization analysis showed that changes in
ODC activities correlated well with the ODC mRNA level,
suggesting that an increase in ODC activity in uremia occurs by
stimulation of transcription or stabilization of mRNA. Further,
the expression of c-fos and c-jun, possible cell growth associated
proto-oncogenes, was also enhanced in uremic intestine, which
was partially reversed by phosphorus restriction. Taken together,
it may be hypothesized that villi in the uremic intestine are
proliferate more than in control intestine, resulting in decreased
calcium absorption. Supporting this finding is that uremic rats
were reported to have consistently longer villi and deeper crypts
[47]. Since enhancement of growth regulating molecule expres-
sion as well as suppression of intestinal function were possibly the
results of impaired phosphate metabolism, it may be hypothesized
that phosphate metabolism is an important determinant of pro-
liferation and differentiation of intestinal epithelial cells.
It seems likely that the effect of phosphorus restriction on
intestinal function and polyamine metabolism in uremia was
mediated in part by the increase of 1,25-(OH)2D, as suggested by
the following findings. First, a decrease in serum 1,25-(OH)2D
levels in uremic rats was restored partially by phosphorus restric-
tion as reported previously [22,23]. Second, changes of expression
of the calbindin-D9k gene, one of the 1,25-(OH)2D-dependent
cytosolic calcium-binding proteins, were in good agreement with
those of intestinal calcium absorption. This protein was shown to
be involved in intracellular calcium transport and homeostasis
[48]. Finally, a single injection of 1,25-(OH)2D3 to uremic rats
caused decreases in steady state levels of ODC and c-fos mRNAs,
and a dramatic rise in the calbindin-D9k mRNA level. These
changes were similar to those induced by a phosphorus-restricted
diet in uremic rats. l,25-(OH)2D3 treatment also caused the
serum PTH level to decrease at 6 to 24 hours (data not shown).
Since changes in levels of ODC and c-fos mRNA after the
1,25-(OH)2D3 treatment preceded that of serum PTH level, it
seems unlikely that PTH mediated the effect of 1,25-(OH)2D3 in
suppressing the gene expression of these genes.
It was reported that administration of vitamin D to vitamin
D-deficient chicks and rats resulted in considerable growth in the
villi [31, 32], which was associated with increases in duodenal
ODC and SAT activities and in the tissue content of putrescine.
As known, intestinal mucosal cells originate in progenitor cells
present in the crypt region of the villi and differentiate and
migrate toward the villus tips. Shinki et al [35] suggested that SAT
activity was intimately involved in calcium absorption because it is
at high levels in the villus tips. In contrast, the activity of ODC was
reported to be located predominantly in the crypt region and in
the lower part of villi [351, suggesting an essential role for ODC
and putrescine in the regulation of epithelial cell proliferation. As
speculated from these findings, an increase in ODC activity in
uremia may be a feature of intestinal epithelial cell proliferation,
while a decrease in SAT activity could be related to impaired
intestinal calcium absorption. So putrescine, the product of ODC
and SAT, is somehow involved in the 1,25-(OH)2D action in
maintaining the morphological and functional development of the
intestinal villus mucosa. A single injection of 1,25-(OH)2D3 into
vitamin D-deficient chicks produces a marked increase of pu-
trescine accumulation in the duodenum [33, 36]. Administering
specific inhibitors of putrescine synthesis to newborn chicks
significantly decreased the duodenal content of putrescine in
association with a reduction in calcium transport activity. The
putrescine depletion also induced shortening of the duodenal
villus length. The inhibition of calcium absorption and villus
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3
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length in the putrescine-depleted chicks was almost completely
restored by administering putrescine to the birds. The effect of the
putrescine depletion and its supplementation on the duodenal
villus length and the calcium absorption was reproduced in
5-week-old vitamin D-deficient chicks given vitamin D3 or 1,25-
(OH)2D3. Therefore, taking these findings into consideration
together with our results, it seems possible to conclude that the
decrease in intestinal calcium transport activity and the expression
of calbindin D9k mRNA in uremic rat intestine may arise from the
impairment of polyamine biosynthesis. The locations of ODC and
SAT activities in uremic intestine and the difference between
uremic and normal intestine need to be elucidated to prove this
theory.
Of note is that ODC activity and its gene expression were
down-regulated by 1,25-(OH)2D3 in uremia, in contrast to the
up-regulation in vitamin D-deficient animal models [33—35]. It is
somewhat difficult to understand the mechanism of this phenom-
enon from our current results. However, the response of uremic
intestine to 1,25-(OH)2D3 seems to be complicated compared to
vitamin D-deficient intestine, that is, attenuated up-regulation of
vitamin D receptor and potentiated induction of 24-hydroxylase
gene expression as described previously [18]. We have recently
shown that maturation of intestinal epithelial cells was impaired in
uremic state as evidenced by the distribution of 24-hydroxylase
[491 and by increased expressions of PKC a, PKC b, and PKC
[501. In this study, we have further demonstrated the impairment
of the differentiation of intestinal epithelial cells as evidenced by
decreases of differention markers such as calcium transport
activity, calbindin D9k expression and SAT activity. As a result of
the impairment of the differentiation, the proliferation of intesti-
nal epithelial cells seemed enhanced in uremic state, which is in
sharp contrast to the vitamin D-deficient state. The enhanced
proliferation of intestinal epithelial cells was reflected by: (i) the
morphological study indicating a considerable increase in the
villus length and (ii) increases of proliferation markers such as
ODC activity and its gene expression, and oncogene expressions.
1,25-(OH)2D is known to stimulate both proliferation and differ-
entiation of intestinal epithelial cells. In vitamin D deficient state,
both processes are impaired. Administration of 1,25-(OH)2D to
vitamin D deficient animal normalized both impairment in such
state. However, since only differentiation is impaired in uremic
state in association with the resultant enhancement of prolifera-
tion, when differentiation impairment is normalized by 1,25-
(OH)2D3 administration, the enhanced proliferation should be
reduced to a normal level. Therefore, 1,25-(OH)2D seems to have
an effect on the proliferation of intestinal epithelial cells in a
uremic state totally different from that in a vitamin D-deficient
state.
In summary, altered polyamine metabolism existed and was
probably associated with impaired intestinal function in rats with
chronic renal failure. Phosphate metabolism was an important
regulator of intestinal polyamine metabolism and calcium absorp-
tion, which is mediated, at least in part, by 1,25-(OH)2D.
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